Finally, we evaluated inhibitor target engagement in selected biochemical assays, including specific double mutants associated with acquired resistance towards KRAS inhibitors. Our results highlight the key dynamic interactions of these compounds in the SII-P when in complex with KRAS, thereby providing new insights and understanding on the SII-P dynamic behavior and further understanding of KRAS SII-P binding drugs characteristics.